Study finds CD14-positive EVs are a novel biomarker of HCC and cholangiocarcinoma liquid biopsy that permit a non-invasive assessment of the presence and possible extent of these cancers in patients with advanced liver diseases (119). The gene discussed is CD14; the disease is hepatocellular carcinoma.